Financial Performance Overview

Yatharth Hospital & Trauma Care Services Limited reported exceptional financial results for FY 2025-26, with consolidated revenue growing 36.31% to ₹12,071.72 million and net profit surging 53% to ₹1,753.80 million. Basic EPS increased to ₹18.20 from ₹14.72 in the previous year. The standalone business reported revenue of ₹5,918.84 million with net profit of ₹954.10 million (9% growth).

Operational Expansion and Acquisitions

The company significantly expanded its network through strategic acquisitions, including:

  • Shantived Institute of Medical Sciences: Acquired 100% controlling interest for ₹2,600 million, adding a 150-bed hospital in Agra (expandable to 250 beds)
  • MGS Infotech Research & Solutions: Acquired 60% controlling interest for ₹1,520 million, adding a 400-bed hospital in Faridabad

This expansion brings Yatharth's total network to nine hospitals with over 2,800 beds across Noida, Greater Noida, Faridabad, New Delhi, Jhansi-Orchha, and Agra, with JCI and NABH accreditations.

Corporate Governance and AGM Proceedings

The 19th Annual General Meeting was convened on September 25, 2026 via video conference, with shareholders approving seven resolutions including:

  • Adoption of FY26 financial statements and re-appointment of Dr. Ajay Kumar Tyagi as director
  • Ratification of cost auditor remuneration and approval of ₹150 crore loan to subsidiary MGS Infotech
  • Revision of IPO proceeds utilization timeline to March 31, 2027
  • Approval of new ESOP 2026 scheme for 250,000 options and extension to subsidiary employees

Remote e-voting was conducted through CDSL from September 22-24, 2026, with Saurav Upadhyay appointed as scrutinizer.

Financing and Capital Structure

The company secured significant new borrowings of ₹2,238.89 million, including term loans from Kotak Mahindra Bank and Bajaj Finance, increasing total borrowings to ₹2,533.31 million from ₹40.99 million in FY25. Assets worth ₹1,055.32 million were pledged as security. The group maintained a strong equity position of ₹17,805.62 million with cash reserves of ₹2,210.99 million.

Corporate Compliance and Governance

Yatharth maintained full compliance with SEBI LODR regulations and Companies Act requirements. All statutory auditors issued unqualified reports, and the company established robust committee structures including Risk Management, CSR, and Banking committees. Shareholders approved Ramesh Krishnan's appointment as independent director via postal ballot with 92.76% votes in favor.

Subsidiary Operations and Related Party Transactions

The consolidated financial statements include six subsidiaries contributing to overall growth. Key related party transactions included ₹211.20 million borrowings from Shree Rama Roadways at 9% interest and CSR expenditure of ₹22.50 million with Yatharth Foundation for Development.

Outlook and Strategic Positioning

With strong financial performance, expanded network capacity, and approved growth initiatives including ESOP scheme and revised IPO fund utilization, Yatharth Hospital is well-positioned for continued expansion in the North Indian healthcare market while maintaining high standards of corporate governance and regulatory compliance.